Skip to content

Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease

Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02145702
Enrollment
20
Registered
2014-05-23
Start date
2014-05-31
Completion date
2017-12-31
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, End-Stage Renal Disease

Keywords

ESRD, Kidney Failure, Exercise, Cognitive impairment

Brief summary

The purpose of this study is to evaluate the impact of 12 weeks of exercise on cognition in patients with end stage renal disease.

Detailed description

Patients with end stage renal disease have higher cognitive impairment than general population. They also have decreased physical and functional capacity. Exercise has shown to improve cognition in general population. This study will evaluate if exercise improves cognition in dialysis patients. It will also evaluate whether exercise affects performance in daily activities, mood or depression and inflammatory markers in the blood.

Interventions

OTHERAerobic Exercise

Each exercise session will be conducted at the KUMC Exercise and Cardiovascular Health (REACH) Laboratory. Exercise sessions will include a warm-up period, exercise period and a cool down period. Exercise intervention individualized based on health of participant. Subject will be asked to completed two exercise sessions per week for 12 weeks.

PROCEDUREStandard Care Dialysis

12 weeks of standard of care.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with ESRD on dialysis * Age greater than 20 years * Have means of transportation to and from the exercise session * Speak English (as the neuropsychological tests will be performed in English)

Exclusion criteria

* Recent myocardial infarction (within 6 weeks), unstable angina, uncontrolled arrhythmias, congestive heart failure (\> NYHA grade II) * History of stroke in the last 2 months * Active respiratory disease * Uncontrolled hypertension * Severe uncontrolled diabetes * Persistent predialysis hyperkalemia * Active decompensated liver disease * Symptomatic peripheral vascular disease * Musculoskeletal abnormalities that will be prohibit their participation in the exercise program * Health conditions needing frequent hospitalizations * Other health conditions causing inability to follow exercise program correctly * Unwillingness to participate in structured exercise program * Current use of antipsychotics or anti-epileptics * Inability to hear, read or write which will limit their ability to perform the cognitive tests

Design outcomes

Primary

MeasureTime frameDescription
FeasibilityUp to 26 WeeksSubject compliance with exercise training

Secondary

MeasureTime frameDescription
Cognitive functionBaseline, within1 week before and within 1 week after exercise interventionMeasured using a standard battery of neuropsychological tests.
Markers of inflammationBaseline, within 1 week before and within 1 week after exercise interventionMarkers of inflammation will be evaluated before and after exercise intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026